| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/12/1994 | EP0578002A1 Imidazolyl substituted phenylpropionic and cinnamic acid derivatives |
| 01/12/1994 | EP0577957A1 8-Chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine |
| 01/12/1994 | EP0577913A1 Pharmaceutical preparation |
| 01/12/1994 | EP0577904A1 Lactic bacteria |
| 01/12/1994 | EP0577847A1 Morphinan derivative and medicinal use |
| 01/12/1994 | EP0577785A1 Fluorinated compounds as oxygen transport agents |
| 01/12/1994 | EP0577772A1 Ibuprofen-antitussive combinations |
| 01/12/1994 | EP0577769A1 Pharmaceutical compositions and methods for preventing skin tumor formation and causing regression of existing tumors |
| 01/12/1994 | EP0577760A1 Sequential dosing of antifungal and antiinflammatory compositions |
| 01/12/1994 | EP0577757A1 Ibuprofen-decongestant combinations |
| 01/12/1994 | EP0577756A1 New non-anticoagulant heparin derivatives |
| 01/12/1994 | EP0577753A1 Bis-naphthalimides containing amino-acid derived linkers as anticancer agents |
| 01/12/1994 | EP0577737A1 Chromans and thiochromans with heteroarylethynyl substituents at the 7-position having retinoid-like biological activity |
| 01/12/1994 | EP0577726A1 Fat substitute compositions having reduced laxative effects |
| 01/12/1994 | EP0577725A1 Targeted drug delivery via mixed phosphate derivatives |
| 01/12/1994 | EP0577716A1 New non-anticoagulant heparin derivatives |
| 01/12/1994 | EP0577690A1 Organosulphur compounds useful for the treatment of glaucoma |
| 01/12/1994 | EP0577648A1 Novel protein polycation conjugates |
| 01/12/1994 | EP0577646A1 Sustained release drug delivery devices |
| 01/12/1994 | EP0577602A1 Transdermal contraceptive formulations, methods and devices |
| 01/12/1994 | EP0423269B1 Heteroaryl-3-oxo-propanenitrile derivatives useful in the treatment of rheumatoid arthritis and other autoimmune diseases |
| 01/12/1994 | EP0422109B1 Reduction of cell proliferation and enhancement of nk-cell activity |
| 01/12/1994 | EP0382716B1 Use of commercial lecithin as skin penetration enhancer |
| 01/12/1994 | EP0374184B1 Cell growth inhibitors and methods of treating cancer and cell proliferative diseases |
| 01/12/1994 | EP0287652B1 Serum-free medium for the proliferation of lymphokine-activated killer cells |
| 01/12/1994 | CN1080639A Inhibitors of 5-alpha-testosterone reductase |
| 01/12/1994 | CN1080634A Cyclopentane-and-pentene-b-amino acids |
| 01/12/1994 | CN1080541A Multi-function medicine for curing frostbite |
| 01/12/1994 | CN1080528A Rifampin paste preparing process |
| 01/12/1994 | CN1080527A Antifungal composition for external application |
| 01/12/1994 | CN1080526A Method for treatment of infecting illness, antisepsis of cosmetic, antiseptic and antimouldic agent, and cosmetic |
| 01/12/1994 | CN1080525A Pharmaceutical compositions |
| 01/12/1994 | CN1080524A Film controlling type skin permeated paste medicine preparing process |
| 01/12/1994 | CN1080523A Nasal cavity medicine and preparing process |
| 01/12/1994 | CN1023485C Substituted silyl alkylene amines |
| 01/12/1994 | CN1023484C 4-(2-pyrimidinyl)-1-piperazinyl heterocylic carbonyl derivatives and the prepn. |
| 01/12/1994 | CN1023483C Novel process for production of the dextrorotatory optical isomer of diastereomer a of ym-09730 |
| 01/12/1994 | CN1023481C 2-thiophenyloxyaetic acids, process for their prepn. and pharmaceutical preparations containing them |
| 01/12/1994 | CN1023480C 3-aryl-5-alkylthio-4h-1,2,4-triazoles derivatives and prepn. method therefor |
| 01/12/1994 | CN1023479C Process for prepn. of ethylenediamine monoamide derivatives |
| 01/12/1994 | CN1023478C Process for preparing new compound |
| 01/12/1994 | CN1023443C Desensitizing paste for curing primery dentine hypersensitive |
| 01/11/1994 | US5278332 Ethers of myoinsitol phosphate for drugs or foods |
| 01/11/1994 | US5278324 Water soluble derivatives of taxol |
| 01/11/1994 | US5278317 Optically pure R-enantiomer of alpha,alpha-dilower alkyl-pyrrolidine-3-methane amines |
| 01/11/1994 | US5278310 Methyl piperidine derivatives of cinnamic acids, benzoic acids, benzoazols and benzophenones useful as skin anti-aging compounds |
| 01/11/1994 | US5278307 Process for preparing 4-hydroxypyrrolo(2,3-d)pyrimidine based antifolate compounds and intermediates |
| 01/11/1994 | US5278296 Production of hydroxysteryl glycoside compounds |
| 01/11/1994 | US5278288 Contacting milk raw materials containing the glycomacropeptide with cation exchanger to adsorb a fraction of the material, collecting a nonadsorbed fraction, concentrating and desalting the fraction |
| 01/11/1994 | US5278192 Administering isobutyl nitrite and isoamyl nitrite |
| 01/11/1994 | US5278190 Increasing REM stage of sleep and duration of sleep by administering amino acid solution including at least 60% branched-chain amino acids |
| 01/11/1994 | US5278189 Prevention and treatment of occlusive cardiovascular disease with ascorbate and substances that inhibit the binding of lipoprotein (A) |
| 01/11/1994 | US5278187 Pharmaceutical compositions |
| 01/11/1994 | US5278185 Piperidine, Tetrahydropyridine and pyrrolidine compounds |
| 01/11/1994 | US5278184 Synthetic derivatives of pyrrole and pyrrolidine suitable for the therapy of infections caused by rhinoviruses |
| 01/11/1994 | US5278183 Method for the treatment of autoimmune diseases |
| 01/11/1994 | US5278177 Enzyme inhibitory |
| 01/11/1994 | US5278174 Sigma binding site agents |
| 01/11/1994 | US5278173 Administering a 4-aminoquinolines |
| 01/11/1994 | US5278172 Method and composition for treating tendon or joint inflammation using a vasodilator |
| 01/11/1994 | US5278171 Anticholesterol, antilipemic agents |
| 01/11/1994 | US5278169 Administering cromakalim or potassium channel activator |
| 01/11/1994 | US5278168 Biological applications of alkaloids derived from the tunicate Eudistoma sp. |
| 01/11/1994 | US5278166 4-amino-3-heteroaryl butyric acid compounds, compositions, and their use for treating disorders involving a dysfunction of GABAB receptors |
| 01/11/1994 | US5278164 Treatment of anxiety in benzodiazepine-withdrawn patients |
| 01/11/1994 | US5278162 Learning enhancement |
| 01/11/1994 | US5278155 Fluorine-containing vitamin D3 analogues and cell differentiation-inducing agent containing the same |
| 01/11/1994 | US5278154 New vanadium complexes |
| 01/11/1994 | US5278153 Aryl and heteroaryl (phosphinylmethyl)phosphonate squalene synthetase inhibitors and method |
| 01/11/1994 | US5278150 Vasodilation |
| 01/11/1994 | US5278148 Hypotensive agents |
| 01/11/1994 | US5278067 Culture product of microorganism Phoma |
| 01/11/1994 | US5277916 Tetracycline dosage form |
| 01/11/1994 | US5277910 Process for the preparation of a pharmaceutical composition selectively lowering the blood-lipid level |
| 01/11/1994 | US5277907 Regulation of the immune system |
| 01/11/1994 | US5277902 Administering orally with or without silica gel |
| 01/11/1994 | US5277897 Coadministering to a cell |
| 01/11/1994 | US5277895 Nuclear magnetic resonance |
| 01/11/1994 | CA2481110A1 Vitaletheine and use in cell culture and therapy |
| 01/11/1994 | CA2098550A1 Compositions containing retinoic acids and tocopherol |
| 01/11/1994 | CA1326108C Cck antagonists |
| 01/11/1994 | CA1326107C Heterocyclic ketones |
| 01/11/1994 | CA1326040C Magnesium-potassium citrate |
| 01/11/1994 | CA1326038C Iodopropargyl ethers, a process for their preparation and their use |
| 01/11/1994 | CA1326037C Strobilurine derivatives, their preparation and their use |
| 01/11/1994 | CA1326034C Thiazole derivative and leukotriene antagonist containing the same as the effective ingredients |
| 01/11/1994 | CA1326033C Pyrrolidineamide derivative having anti-prolyl endopeptidase activity |
| 01/11/1994 | CA1326032C Tricyclic ketones |
| 01/11/1994 | CA1326030C Cyclohept[b]indolealkanoic acids |
| 01/11/1994 | CA1326029C 4-thiazolidine-carboxylic acid derivative, its preparation and pharmaceutical compositions containing it |
| 01/11/1994 | CA1326026C Optically active benzoquinolizine compounds, process for preparing same, and antibacterial preparation containing same as active ingredient |
| 01/11/1994 | CA1326025C 2-(2-hydroxy-3-phenoxypropylamino)ethylphenoxyacetamides and processes and intermediates for their preparation |
| 01/11/1994 | CA1326022C 6-oxoprostaglandin-e derivatives, method for their manufacture and their use as pharmaceuticals |
| 01/11/1994 | CA1326020C Pharmaceutically useful michaels' addition products of unsaturated aldehydes and ketones with ascorbic acid |
| 01/11/1994 | CA1326018C Method for preparing high purity cristalline lactulose and the product obtained |
| 01/11/1994 | CA1326017C Ribofuranuronic acid derivatives |
| 01/11/1994 | CA1326015C 19,11.beta.-bridged steroids, their manufacture and pharmaceutical preparations containing them |
| 01/11/1994 | CA1326014C 11.beta.-alkynl-estrenes and -estradienes, their production, and pharma ceutial preparations containing them |
| 01/11/1994 | CA1326013C Methods for synthesizing benign prostatic hypertropic agents and their intermediates |
| 01/11/1994 | CA1325977C 5-amino or substituted amino 1,2,3-triazoles useful as antiproliferative agents |